333326-97-9 Usage
Uses
Used in Pharmaceutical Research:
3,5-diaMino-4-(p-acetoaMinophenyl)hydrazonopyrazole is used as a research compound for exploring its potential pharmacological activities. Its unique structure, which includes the hydrazonopyrazole core and the p-acetaminophenyl group, may contribute to its interaction with biological targets, making it a promising candidate for the development of new therapeutic agents.
Used in Drug Development:
In the field of drug development, 3,5-diaMino-4-(p-acetoaMinophenyl)hydrazonopyrazole is utilized as a lead compound for the design and synthesis of novel pharmaceuticals. Its chemical properties and structural features can be further modified to enhance its therapeutic potential, targeting specific diseases or conditions.
Used in Medicinal Chemistry:
3,5-diaMino-4-(p-acetoaMinophenyl)hydrazonopyrazole serves as a key component in medicinal chemistry, where it can be employed to study the structure-activity relationships of various biologically active molecules. Understanding how its structure influences its pharmacological properties can aid in the optimization of drug candidates and the discovery of new therapeutic agents.
Used in Chemical Synthesis:
3,5-diaMino-4-(p-acetoaMinophenyl)hydrazonopyrazole is also used as a building block in chemical synthesis, allowing for the creation of a variety of novel compounds with potential applications in different industries. Its versatile structure can be modified to produce new molecules with unique properties and functions.
Check Digit Verification of cas no
The CAS Registry Mumber 333326-97-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,3,3,2 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 333326-97:
(8*3)+(7*3)+(6*3)+(5*3)+(4*2)+(3*6)+(2*9)+(1*7)=129
129 % 10 = 9
So 333326-97-9 is a valid CAS Registry Number.
333326-97-9Relevant academic research and scientific papers
Pyrazole compounds
-
, (2008/06/13)
Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations
Pyrazole compounds
-
, (2008/06/13)
Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations
Pyrazole compounds
-
, (2008/06/13)
Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.
